Brief: SynAct Pharma Resolves On Directed Share Issue Of 227,203 Shares
Jan 9 (Reuters) - SynAct Pharma AB SYNACT.ST :
* RESOLVES ON DIRECTED SHARE ISSUE OF 227,203 SHARES
* SUBSCRIPTION PRICE IN COMPENSATION ISSUE SET AT SEK 8.65
PER
SHARE
Source text: ID:nMFNbRHC5Y
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026